Monash IVF Group Limited
MNIVF
$0.40
-$0.11-21.57%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.16M | 41.28M | 45.71M | 47.01M | 42.59M |
| Total Other Revenue | -25.60K | -25.10K | 26.10K | 26.80K | 50.10K |
| Total Revenue | 42.13M | 41.26M | 45.74M | 47.03M | 42.64M |
| Cost of Revenue | 28.51M | 27.91M | 30.17M | 31.03M | 28.82M |
| Gross Profit | 13.62M | 13.34M | 15.57M | 16.01M | 13.81M |
| SG&A Expenses | 4.05M | 3.97M | 3.64M | 3.74M | 3.22M |
| Depreciation & Amortization | 3.53M | 3.46M | 3.58M | 3.68M | 2.93M |
| Other Operating Expenses | 983.30K | 962.90K | -900.60K | -926.00K | 15.86M |
| Total Operating Expenses | 37.07M | 36.30M | 36.49M | 37.52M | 50.83M |
| Operating Income | 5.06M | 4.95M | 9.25M | 9.51M | -8.19M |
| Income Before Tax | 3.72M | 3.64M | 7.99M | 8.21M | -9.36M |
| Income Tax Expenses | 1.04M | 1.02M | 2.35M | 2.41M | -3.15M |
| Earnings from Continuing Operations | 2.68M | 2.63M | 5.64M | 5.80M | -6.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -119.80K | -117.30K | -95.80K | -98.50K | -155.20K |
| Net Income | 2.56M | 2.51M | 5.54M | 5.70M | -6.36M |
| EBIT | 5.06M | 4.95M | 9.25M | 9.51M | -8.19M |
| EBITDA | 6.47M | 7.03M | 12.83M | 13.19M | -7.09M |
| EPS Basic | 0.01 | 0.01 | 0.01 | 0.01 | -0.02 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.02 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.01 | -0.02 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.02 |
| Average Basic Shares Outstanding | 389.63M | 389.63M | 389.63M | 389.63M | 389.63M |
| Average Diluted Shares Outstanding | 389.63M | 389.63M | 393.15M | 393.15M | 389.63M |
| Dividend Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Payout Ratio | 126.68% | 126.68% | 57.27% | 57.27% | -50.52% |